Why the Unibail (ASX:URW) share price is rocketing 38% higher

The Unibail Rodamco Westfield share price is soaring higher today, up 38% in late afternoon trading. Here's why.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Unibail Rodamco Westfield (ASX: URW) share price is soaring higher today, up 38% in late afternoon trading after posting earlier intraday gains in excess of 44%.

This comes after the company released the results of the votes on 6 resolutions submitted to its shareholders. The results were initially not expected until after the company's combined general meeting, scheduled for 10 November.

However, due to the COVID-19 pandemic, shareholders voted remotely, and the vote closed early.

Today's surge will come as welcome news to longer-term shareholders, who watched Unibail's share price fall by 75% from 2 January through to yesterday's trading. Even after today's stellar gains, the share price still remains down 65% in 2020.

Man looking excitedly at ASX share price gains on computer screen against backdrop of streamers

Image source: Getty Images

What does Unibail Rodamco Westfield do?

Unibail is one of Europe's largest commercial real estate companies, owning a portfolio of quality retail and office complexes. It has assets in Europe, the United Kingdom and the United States.

Unibail acquired Australian shopping centre operator Westfield Corporation, created by the split of Westfield Group, in 2018. This saw Unibail shares first listing on the ASX. The company makes up part of the S&P/ASX 200 Index (ASX: XJO).

What's driving the Unibail share price leap up?

In an announcement released to the ASX this morning, Unibail revealed the results of its shareholders' votes on 6 resolutions put to them.

But it's likely only one key result that's really spurring today's share price gains.

Unibail reported that shareholders had rejected the management board's resolution to issue ordinary shares with preferential subscription rights. The proposed 3.5 billion euro capital raising was intended to pay down the company's significant debt obligations, as part of what it calls the 'RESET' plan.

While other aspects of the plan – including asset disposals and a reduced cash dividend – can go forward, the capital raising will not.

Addressing the outcome, Group CEO Christophe Cuvillier said:

We take note of the shareholders' votes expressed in view of the Shareholders' General Meeting of November 10, notably regarding the proposed capital increase, which did not gather the required two-third majority.

The Group and our industry are going through a period of uncertainty and disruption; the announcement of a possible first global vaccine against COVID-19 is the most recent illustration of this. This medical breakthrough is tremendous news for all and marks a major step in the global fight against the pandemic. Subject to the approval of the next clinical steps, this could have a significant positive impact on retail real estate in general, on URW in particular, especially on our operations and the completion of our disposal plan.

With the capital raising off the radar and a promising potential vaccine in the near-term pipeline, the Unibail share price is one to watch.

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

A smiling woman at a hardware shop selects paint colours from a wall display.
Broker Notes

Wesfarmers shares: Buy, hold or sell?

A leading analyst delivers his verdict on Wesfarmers shares.

Read more »

An arrow crashes through the ground as a businessman watches on.
Share Fallers

After falling 43% in a week, are Cochlear shares now a buy?

Is this drop a warning sign?

Read more »

Businessman working and using Digital Tablet new business project finance investment at coffee cafe.
Broker Notes

Buy, hold, sell: Cochlear, CSL, and DroneShield shares

Are these hugely popular shares in the buy zone or not? Let's find out.

Read more »

Man holding out $50 and $100 notes in his hands, symbolising ex dividend.
Share Market News

How much do I need to invest in ASX shares to earn a $500 monthly passive income?

A $500 per month passive income is more achievable than you'd think.

Read more »

Man with rocket wings which have flames coming out of them.
Broker Notes

These ASX 200 shares could rise ~40% to 80%

Brokers are predicting big returns for these top shares. Here's what you need to know.

Read more »

3 children standing on podiums wearing Olympic medals.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a lacklustre end to the trading week this Friday...

Read more »

Person pointing at an increasing blue graph which represents a rising share price.
Broker Notes

2 ASX 200 stocks that could rise 50%

Morgans thinks the market is undervaluing these shares.

Read more »

A financial expert or broker looks worried as he checks out a graph showing market volatility.
Technology Shares

I was going to buy these ASX tech stocks. Now, I'm not so sure

When the facts change, so should our buying...

Read more »